Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Keggin-Type Polyoxometalates as a Systematic Antiviral Scaffold: Activity, Cytotoxicity, and Solution Stability across Heteroion and Addenda Metal Variations.

Created on 10 Sep 2026

Authors

Judith Füllborn-Ott, Aliona Dobrova, Nadiia I Gumerova, Ingo Ott, Annette Rompel

Published in

Journal of medicinal chemistry. Volume 69. Issue 17. Pages 20772-20781. Sep 10, 2026.

Abstract

Polyoxometalates (POMs) are promising antiviral agents, yet systematic structure-activity relationships remain scarce and biological stability is rarely assessed. Here we report the antiviral activity, cytotoxicity, and solution speciation of 11 Keggin-type POMs spanning three compositional series─PVxW12-x, PVxMo12-x, and SiMoxW12-x (x = 0-3)─alongside lacunary derivatives, and simple metal salt controls. Multinuclear NMR spectroscopy (31P, 51V, 183W) in cell culture medium under assay conditions revealed a direct correlation between cluster integrity and antiviral potency: compounds that decompose are uniformly inactive while structurally stable or partially transformed clusters show concentration-dependent inhibition. The silicomolybdotungstate series proved most promising, with [SiW12O40]4- and [SiMoW11O40]4- achieving IC50 values of 26.0 and 24.9 μM against HCoV-OC43. Antiviral potency correlates with overall cluster charge, with 4- anions consistently outperforming their 3- and 6- analogues─an observation rationalized through the superchaotropic ion concept.

PMID:
42720479
Bibliographic data and abstract were imported from PubMed on 10 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement